{
  "nodes": [
    {
      "node_id": "A",
      "step_index": 1,
      "data": {
        "demographics": {
          "age": 78,
          "sex": "male"
        },
        "conditions": [
          {
            "diagnosis": "Recurrent, metastatic sacral chordoma",
            "location": ["sacrum", "liver", "lung", "thoracic and lumbar spine"]
          }
        ],
        "treatments": [
          "Surgical resection",
          "Proton beam therapy (42 sessions)",
          "Partial hepatectomy"
        ],
        "observations": [
          "Multiple recurrences",
          "Oligometastatic progression"
        ],
        "labs": [
          {
            "test": "Thymidylate Synthase (TS) immunohistochemistry",
            "result": "Negative"
          }
        ],
        "metadata": {
          "journal_id": "Current Problems in Cancer: Case Reports 17 (2025) 100340",
          "doi": "10.1016/j.cpccr.2024.100340",
          "schema_version": "1.0"
        }
      },
      "commentary": "Initial patient snapshot with multiple treatments and metastatic disease"
    },
    {
      "node_id": "B",
      "step_index": 2,
      "data": {
        "treatments": [
          {
            "medication": "Pemetrexed",
            "dose": "500 mg/m2",
            "frequency": "Every 3 weeks"
          }
        ],
        "observations": [
          "Improvement in liver lesions size after two cycles",
          "Stable lung lesions"
        ]
      },
      "commentary": "Patient initiates pemetrexed treatment with early positive radiological response."
    },
    {
      "node_id": "C",
      "step_index": 3,
      "data": {
        "treatments": [
          {
            "medication": "Pemetrexed",
            "dose": "900 mg/m2",
            "frequency": "Every 3 weeks"
          }
        ],
        "observations": [
          "Further decrease in liver lesions and reduction of lung lesion size",
          "Stable bone lesions",
          "Improved right leg weakness and gait",
          "Increased fatigue and nausea post-infusion"
        ]
      },
      "commentary": "Dose increased, significant clinical improvement noted despite manageable side effects"
    }
  ],
  "edges": [
    {
      "edge_id": "A_to_B",
      "from_node": "A",
      "to_node": "B",
      "step_index": 1,
      "event_type": "Intervention",
      "changes": [
        {
          "field": "treatments",
          "change_type": "add",
          "value": "Pemetrexed initiation"
        },
        {
          "field": "observations",
          "change_type": "update",
          "from": "Disease progression",
          "to": "Improvement in liver lesions, stable lung lesions"
        }
      ],
      "confidence": 0.95,
      "commentary": "Transition to salvage therapy due to progressive metastatic disease and negative TS expression"
    },
    {
      "edge_id": "B_to_C",
      "from_node": "B",
      "to_node": "C",
      "step_index": 2,
      "event_type": "Intervention",
      "changes": [
        {
          "field": "treatments.dose",
          "change_type": "update",
          "from": "500 mg/m2",
          "to": "900 mg/m2",
          "reason": "Patient tolerance and emerging evidence"
        },
        {
          "field": "observations",
          "change_type": "update",
          "from": "Initial radiological response",
          "to": "Continued improvement and symptom resolution"
        },
        {
          "field": "side_effects",
          "change_type": "add",
          "value": ["Fatigue", "Nausea"]
        }
      ],
      "confidence": 0.9,
      "commentary": "Dose escalated based on clinical tolerance, further improvement observed"
    }
  ]
}

